AU2003223934A8 - Recombinant bet. v. 1. allergen mutants, methods and process thereof - Google Patents

Recombinant bet. v. 1. allergen mutants, methods and process thereof

Info

Publication number
AU2003223934A8
AU2003223934A8 AU2003223934A AU2003223934A AU2003223934A8 AU 2003223934 A8 AU2003223934 A8 AU 2003223934A8 AU 2003223934 A AU2003223934 A AU 2003223934A AU 2003223934 A AU2003223934 A AU 2003223934A AU 2003223934 A8 AU2003223934 A8 AU 2003223934A8
Authority
AU
Australia
Prior art keywords
methods
recombinant bet
allergen mutants
allergen
mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003223934A
Other versions
AU2003223934A1 (en
Inventor
Mercedes Ferreras
Jens Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of AU2003223934A8 publication Critical patent/AU2003223934A8/en
Publication of AU2003223934A1 publication Critical patent/AU2003223934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2003223934A 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof Abandoned AU2003223934A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38144002P 2002-05-16 2002-05-16
DKPA200200756 2002-05-16
DKPA200200756 2002-05-16
US60/381,440 2002-05-16
PCT/DK2003/000322 WO2003096869A2 (en) 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof

Publications (2)

Publication Number Publication Date
AU2003223934A8 true AU2003223934A8 (en) 2003-12-02
AU2003223934A1 AU2003223934A1 (en) 2003-12-02

Family

ID=29551230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003223934A Abandoned AU2003223934A1 (en) 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof

Country Status (6)

Country Link
EP (1) EP1504089A2 (en)
CN (1) CN1668737A (en)
AU (1) AU2003223934A1 (en)
CA (1) CA2486112A1 (en)
PL (1) PL212139B1 (en)
WO (1) WO2003096869A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2116257T3 (en) 2000-08-09 2013-02-04 Alk Abello As Parenteral vaccine formulations and applications thereof
MXPA05005528A (en) 2002-11-26 2006-04-05 Alk Abello As Pharmaceutical allergen product.
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2548249C (en) 2003-12-19 2013-02-12 Alk-Abello A/S Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
ATE468135T1 (en) * 2004-11-10 2010-06-15 Alk Abello As METHOD FOR THE PREVENTIVE TREATMENT OF ALLERGIES BY ADMINISTRATION OF AN ALLERGY VACCINE TO THE MUCOUS MEASURES
CA2624503A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (en) 2005-12-29 2007-06-30 Lofarma Spa VARIANBTIO HYPOALLERGENICS OF ALLERGENE GREATER BET V 1 BERRY OF BETULA VERRUCOSA
FI20075059A0 (en) 2007-01-29 2007-01-29 Valtion Teknillinen Allergen-binding monoclonal IgE antibodies and hypoallergenic genes: Immunocomplex interaction between type I IgE and allergen
CN101674845A (en) 2007-03-28 2010-03-17 阿尔克-阿贝洛有限公司 The purposes that is used for the adjuvanted allergy vaccine formulation of parenteral
EP2022507A1 (en) * 2007-08-07 2009-02-11 Universität Hamburg Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
DE202008006598U1 (en) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergy vaccine formulation for mucosal administration
ES2606550T3 (en) 2009-06-19 2017-03-24 Alk-Abelló S.A. New way of administering allergen in specific immunotherapy with allergens
FI20115375A0 (en) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
FI20115374A0 (en) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
ITMI20111489A1 (en) * 2011-08-03 2013-02-04 Lofarma Spa HYPOALLERGENIC VARIATIONS OF ALLERGENE MORE MAL MAL 1 OF DOMESTIC MALUS
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111718912B (en) * 2020-05-20 2021-11-02 华中农业大学 Flavanone-3-hydroxylase antigen epitope peptide, antibody and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9052891A (en) * 1990-12-05 1992-07-08 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
DK1062341T3 (en) * 1998-03-16 2008-11-03 Alk Abello As Mutant recombinant allergens
DE69938435D1 (en) * 1998-10-30 2008-05-08 Novozymes As Low allergenic protein variants
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy
EP2236611A1 (en) * 2000-04-28 2010-10-06 Novozymes A/S Lipolytic enzyme variant
NZ525820A (en) * 2000-11-16 2005-01-28 Alk Abello As Mutant allergens
CA2469078A1 (en) * 2001-12-05 2003-06-12 Circassia Limited Immunotherapeutic methods and systems

Also Published As

Publication number Publication date
WO2003096869A2 (en) 2003-11-27
CN1668737A (en) 2005-09-14
PL373086A1 (en) 2005-08-08
PL212139B1 (en) 2012-08-31
CA2486112A1 (en) 2003-11-27
AU2003223934A1 (en) 2003-12-02
EP1504089A2 (en) 2005-02-09
WO2003096869A3 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
AU2003223934A8 (en) Recombinant bet. v. 1. allergen mutants, methods and process thereof
AU2003286611A1 (en) Cytomodulating peptides and methods for treating neurological disorders
EP1201773A4 (en) High-strength spring and production method therefor
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
AU2002337497A1 (en) Carbon material, production method and use thereof
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2003222408A1 (en) Garment and method for producing the same
MXPA03002248A (en) Colour- and/or effect-producing multicoat lacquer, method for production and use thereof.
EP1273658A4 (en) Novel protein, dna thereof and process for producing the same
HK1072948A1 (en) Ifnar2 mutants, their production and use
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2003220967A1 (en) Conductive member and process for producing the same
EP1582589A4 (en) Protein complex, process for producing the same and use thereof
EP1273657A4 (en) Novel protein, process for producing the same and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
EP1489087A4 (en) Bisphosphine, process for producing the same, and use thereof
AU2001268108A1 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
AU2002365189A8 (en) P85-alpha nucleic acids, polypeptides and related methods
ZA200102692B (en) Treated manganese ore, process for producing the same, and use thereof.
AU2001231484A1 (en) A novel polypeptide, secp43, 32 that associates specifically with human selecnocysteine trna and the polynucleotide encoding thereof
EP1331269A4 (en) Novel protein, process for producing the same and use thereof
AU2003272914A1 (en) Fine spherical particles with satisfactory molecular orientation, spherical microcapsules comprising the same, and processes for producing these
ZA200204012B (en) Zinc electrode and its production process.
IL162507A0 (en) Ifnar2 mutants, their production and use
AU2002259238A1 (en) Dwf12 and mutants thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase